Jiangsu GDK Biotechnology Co Ltd Net Assets

Latest as of March 2026: CN¥1.08 Billion CNY ≈ $157.56 Million USD

Jiangsu GDK Biotechnology Co Ltd net assets. Based on the latest financial reports, Jiangsu GDK Biotechnology Co Ltd (688670) has net assets worth CN¥1.08 Billion CNY (≈ $157.56 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.36 Billion ≈ $198.42 Million USD) and total liabilities (CN¥279.22 Million ≈ $40.86 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of Jiangsu GDK Biotechnology Co Ltd to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥1.08 Billion
% of Total Assets	79.41%
Annual Growth Rate	N/A
5-Year Change	-24.79%
10-Year Change	N/A
Growth Volatility	203.79

Net Assets of Jiangsu GDK Biotechnology Co Ltd (2017–2025)

Net assets of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025. This chart illustrates how Jiangsu GDK Biotechnology Co Ltd's net assets have evolved over time, based on quarterly financial data. See 688670 equity to assets ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Jiangsu GDK Biotechnology Co Ltd (2017–2025)

The table below shows the annual net assets of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025. For live market cap and overall valuation, see Jiangsu GDK Biotechnology Co Ltd market cap and net worth.

Year	Net Assets	Change
2025-12-31	CN¥1.10 Billion ≈ $160.83 Million	-13.97%
2024-12-31	CN¥1.28 Billion ≈ $186.95 Million	-6.82%
2023-12-31	CN¥1.37 Billion ≈ $200.63 Million	-6.07%
2022-12-31	CN¥1.46 Billion ≈ $213.60 Million	-0.12%
2021-12-31	CN¥1.46 Billion ≈ $213.84 Million	+502.62%
2020-12-31	CN¥242.50 Million ≈ $35.49 Million	+323.75%
2019-12-31	CN¥-108.38 Million ≈ $-15.86 Million	-21.31%
2018-12-31	CN¥-89.34 Million ≈ $-13.07 Million	-45.68%
2017-12-31	CN¥-61.33 Million ≈ $-8.97 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Jiangsu GDK Biotechnology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 5539404521.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Jiangsu GDK Biotechnology Co Ltd Net Assets Breakdown (December 2025)

Jiangsu GDK Biotechnology Co Ltd net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Other Components	CN¥1.27 Billion	115.17%
Total Equity	CN¥1.10 Billion	100.00%

Jiangsu GDK Biotechnology Co Ltd Competitors by Market Cap

The table below lists competitors of Jiangsu GDK Biotechnology Co Ltd ranked by their market capitalization.

Company	Market Cap
Batavia Prosperindo Int JK:BPII	$231.67 Million
Launchpad Cadenza Acquisition Corp I Class A Ordinary Share NASDAQ:LPCV	$231.84 Million
Cantabil Retail India Limited NSE:CANTABIL	$231.87 Million
Kaltura Inc NASDAQ:KLTR	$231.88 Million
Nautilus Biotechnology Inc NASDAQ:NAUT	$231.60 Million
Sakar Healthcare Limited NSE:SAKAR	$231.58 Million
Chongqing Wanli New Energy Co Ltd SHG:600847	$231.49 Million
TYC Brother Industrial Co Ltd TW:1522	$231.46 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Jiangsu GDK Biotechnology Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 1,277,578,797 to 1,099,114,043, a change of -178,464,754 (-14.0%).
Net loss of 173,473,600 reduced equity.
Dividend payments of 1,256,201 reduced retained earnings.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥-173.47 Million	-15.78%
Dividends Paid	CN¥1.26 Million	-0.11%
Other Changes	CN¥-3.73 Million	-0.34%
Total Change	CN¥-	-13.97%

Book Value vs Market Value Analysis

This analysis compares Jiangsu GDK Biotechnology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.44x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	CN¥-1.22	CN¥12.85	x
2018-12-31	CN¥-1.28	CN¥12.85	x
2019-12-31	CN¥-1.55	CN¥12.85	x
2020-12-31	CN¥2.63	CN¥12.85	x
2021-12-31	CN¥13.92	CN¥12.85	x
2022-12-31	CN¥11.95	CN¥12.85	x
2023-12-31	CN¥11.20	CN¥12.85	x
2024-12-31	CN¥10.38	CN¥12.85	x
2025-12-31	CN¥8.93	CN¥12.85	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Jiangsu GDK Biotechnology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -15.78%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -153.20%
• Asset Turnover: 0.08x
• Equity Multiplier: 1.29x
Recent ROE (-15.78%) is below the historical average (4.90%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2017	0.00%	0.00%	0.00x	0.00x	CN¥-26.53 Million
2018	0.00%	0.00%	0.00x	0.00x	CN¥-19.08 Million
2019	0.00%	-28.35%	0.17x	0.00x	CN¥-8.20 Million
2020	63.91%	26.31%	0.76x	3.21x	CN¥130.73 Million
2021	5.64%	21.02%	0.22x	1.20x	CN¥-63.68 Million
2022	2.85%	13.04%	0.17x	1.25x	CN¥-104.42 Million
2023	-5.18%	-52.75%	0.08x	1.19x	CN¥-208.10 Million
2024	-7.32%	-115.72%	0.05x	1.20x	CN¥-221.26 Million
2025	-15.78%	-153.20%	0.08x	1.29x	CN¥-283.39 Million

Industry Comparison

This section compares Jiangsu GDK Biotechnology Co Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $4,249,539,151
Average return on equity (ROE) among peers: 8.37%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Jiangsu GDK Biotechnology Co Ltd (688670)	CN¥1.08 Billion	0.00%	0.26x	$231.66 Million
Shenzhen CAU Technology Co Ltd (000004)	$201.21 Million	7.82%	2.01x	$9.88 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403)	$57.54 Million	0.00%	2.33x	$1.35 Billion
Nanhua Bio Medicine Co Ltd (000504)	$110.54 Million	0.00%	1.02x	$385.86 Million
Jiangsu Sihuan Bioengineering Co Ltd (000518)	$642.80 Million	-4.58%	0.44x	$464.02 Million
Chengzhi Shareholding Co Ltd (000990)	$1.02 Billion	4.98%	1.21x	$1.28 Billion
Hualan Biological EngineeringInc (002007)	$5.77 Billion	19.74%	0.12x	$3.29 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030)	$914.64 Million	16.73%	0.74x	$1.08 Billion
Shanghai RAAS Blood Products Co Ltd Class A (002252)	$31.94 Billion	6.87%	0.05x	$4.77 Billion
Baolingbao Biology Co Ltd (002286)	$1.44 Billion	2.86%	0.17x	$487.64 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287)	$396.33 Million	29.23%	0.30x	$1.62 Billion

About Jiangsu GDK Biotechnology Co Ltd

SHG:688670 China Biotechnology

Market Cap

$231.66 Million

CN¥1.58 Billion CNY

Market Cap Rank

#15718 Global

#4576 in China

Share Price

CN¥12.85

Change (1 day)

-2.06%

52-Week Range

CN¥11.85 - CN¥30.90

All Time High

CN¥75.07